FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), announces that it has signed a non-binding agreement to acquire Vector Biosource Inc. (“Vector”). Vector is an information and biospecimen sourcing provider serving the biotechnology, clinical research and pharmaceutical research industries. Vector expects to generate $800,000 of revenues in 2025 without additional capital. “We were attracted to Vector’s unique position in this healthcare sector, and its growth profile, and we are focused on working closely with Vector senior leadership to aggressively expand the Vector platform,” said Seamus Lagan, CEO of FOXO.
Read the full article: FOXO Technologies Inc. Announces Execution of a Non Binding Agreement to Acquire Vector Biosource Inc. //
Source: https://www.globenewswire.com/news-release/2025/03/19/3045353/0/en/FOXO-TECHNOLOGIES-INC-ANNOUNCES-EXECUTION-OF-A-NON-BINDING-AGREEMENT-TO-ACQUIRE-VECTOR-BIOSOURCE-INC.html